Project OASIS-2

Basic data

Title:
OASIS-2
Duration:
01/09/2018 to 31/03/2020
Abstract / short description:
Multicenter, Randomized, DoubleBlind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients with Moderateto-Severe Plaque Psoriasis (OASIS-2)
Prüfplan-Nr.: 16T-MC-AMAJ

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Basingstoke, Hampshire, United Kingdom
Help

will be deleted permanently. This cannot be undone.